Aciphex
NDC 80725-243, rabeprazole sodium, tablet, delayed release, from Waylis Therapeutics LLC.
- Product NDC
- 80725-243
- Status
- Listed
- Labeler
- Waylis Therapeutics LLC
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020973
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/80725-243 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RABEPRAZOLE SODIUM20 mg/1
Pharmacologic classes
Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 80725-243-30 | 80725024330 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (80725-243-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1eb38279-0237-4967-be7a-c53a826c1138
Use it
Look up 80725-243 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/80725-243 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 80725-243. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.